K220265 is an FDA 510(k) clearance for the ADVIA Centaur® NT-proBNPII (PBNPII). This device is classified as a Test, Natriuretic Peptide (Class II - Special Controls, product code NBC).
Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on September 24, 2023, 601 days after receiving the submission on January 31, 2022.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1117.
| 510(k) Number | K220265 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | January 31, 2022 |
| Decision Date | September 24, 2023 |
| Days to Decision | 601 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NBC — Test, Natriuretic Peptide |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1117 |